- PLN36.40m
- PLN51.87m
- PLN60.90m
Brief: BioMaxima Management To Recommend 2020 Dividend Of 0.25 Zloty/Shr
Brief: Biomaxima Gets Order For Sars-Cov-2 Tests From Contractor In Spain
Brief: BioMaxima Q4 Net Profit Up At 3.4 Mln Zlotys
Brief: BioMaxima Dec Sales Revenue Up 236% Y/Y
Brief: Biomaxima Jan-Aug Sales 18.8 Mln Zlotys, Up 3.75% Y/Y
Brief: Biomaxima Q2 Net Result Turns To Loss Of 0.1 Mln Zlotys
Brief: Biomaxima Jan-July Revenue At 16.8 Mln Zlotys, Up 3.95% Y/Y
Brief: BioMaxima Signs Loan Agreement For 2.5 Mln Zlotys
Brief: Biomaxima Jan-June Revenue 14.5 Mln Zlotys, Up 2.0% YoY
Brief: Biomaxima Jan-May 2019 Revenue 12.2 Mln Zlotys, Up 6.51%
Brief: Biomaxima Gets 0.6 Mln Zloty Subsidy For R&D Project
Brief: Biomaxima Q1 Net Result Turns To Loss Of 0.2 Mln Zlotys
Brief: Biomaxima Q1 Sales Down At 7.0 Million Zlotys
Brief: Biomaxima Q4 Net Result Turns To Loss Of 10,125 Zlotys
Brief: Biomaxima January Revenue 2.1 Million Zlotys
Brief: Biomaxima Applies For Registration Of Biochemical Analyzer In Poland
Brief: Biomaxima Q3 Net Result Turns To Loss 0.6 Mln Zlotys
Brief: Biomaxima 9-Month Revenue Slightly Down At 20.8 Mln Zlotys
Brief: Biomaxima Signs Deal On Exclusive Distribution Of Accelerate Diagnostics Products In Poland